BioStem Technologies, Inc. (BSEM) Misses Q3 EPS by 44c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BSEM Hot Sheet
Join SI Premium – FREE
BioStem Technologies, Inc. (NASDAQ: BSEM) reported Q3 EPS of ($0.52), $0.44 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $11 million.
GUIDANCE:
BioStem Technologies, Inc. sees FY2026 revenue of $26-29 million, versus the consensus of $29.004 million.
For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbnb (ABNB) call put ratio 1 call to 1.3 puts into quarter results
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
- Flutter Entertainment plc (FLUT) Misses Q3 EPS by 525c; lowers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
